Finally, Zheng et al. (2011) showed that the Nrf2-specific agonists [(sulforaphane (SFN) and cinnamic aldehyde (CA)] do not have protective effects in Nrf2-null diabetic mice suffering from DN. Here, NFE2L2 is linked to liver dysplastic nodule.